Literature DB >> 25111927

Translating evidence into practice using a systems engineering framework for infection prevention.

Eric Yanke1, Pascale Carayon, Nasia Safdar.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 25111927     DOI: 10.1086/677638

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


× No keyword cloud information.
  4 in total

1.  Understanding the current state of infection prevention to prevent Clostridium difficile infection: a human factors and systems engineering approach.

Authors:  Eric Yanke; Caroline Zellmer; Sarah Van Hoof; Helene Moriarty; Pascale Carayon; Nasia Safdar
Journal:  Am J Infect Control       Date:  2015-03-01       Impact factor: 2.918

2.  Implementation of a Clostridioides difficile prevention bundle: Understanding common, unique, and conflicting work system barriers and facilitators for subprocess design.

Authors:  Jackson S Musuuza; Ann Schoofs Hundt; Pascale Carayon; Karly Christensen; Caitlyn Ngam; Nicholas Haun; Nasia Safdar
Journal:  Infect Control Hosp Epidemiol       Date:  2019-06-13       Impact factor: 3.254

3.  Reported hours of infection education received positively associated with student nurses' ability to comply with infection prevention practices: Results from a nationwide survey.

Authors:  Eileen J Carter; Diane Mancino; Amanda J Hessels; Ana M Kelly; Elaine L Larson
Journal:  Nurse Educ Today       Date:  2017-03-02       Impact factor: 3.442

4.  Effect of an Intervention Package and Teamwork Training to Prevent Healthcare Personnel Self-contamination During Personal Protective Equipment Doffing.

Authors:  Jennifer Andonian; Sadaf Kazi; Jennifer Therkorn; Lauren Benishek; Carrie Billman; Margaret Schiffhauer; Elaine Nowakowski; Patience Osei; Ayse P Gurses; Yea-Jen Hsu; David Drewry; Ellen R Forsyth; Arjun Vignesh; Ifeoluwa Oresanwo; Brian T Garibaldi; Kaitlin Rainwater-Lovett; Polly Trexler; Lisa L Maragakis
Journal:  Clin Infect Dis       Date:  2019-09-13       Impact factor: 9.079

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.